Bibliografisk träff 2022-04-11 Discovery and preclinical evaluations of WX-0593, a novel ALK inhibitor targeting crizotinib-resistant mutations. Liu X, Zhang L, Wan H, Zhu Z, Jin J, Qin Y, Mao W, Yan K, Fang D, Jiang W, Hu L, Chen J, Chen K, Chen S, Li J, Zhao S, Zheng S, Zhang L, Ding CZ. Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2022.128730